
12 June 2025
Enterome, raises $19 million to fund clinical development of its OncoMimics™ immunotherapies to treat Follicular Lymphoma
Enterome, a clinical-stage company developing first-in-class OncoMimics™ immunotherapies to treat cancer, has raised $19 million in a new private financing.